Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:44 PM
Ignite Modification Date:
2025-12-24 @ 12:44 PM
NCT ID:
NCT02336061
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with stage IV NSCLC who are going to commence first line treatment
* Patients over the age of 18
* ECOG 0-3
* Patients who have granted their informed consent, preferably in writing, but otherwise, verbal with witnesses who are independent of the research team
* Life expectancy of over three months
* Speak fluent Spanish, in order to be able to complete the study questionnaires
* Patients able to read and write with no problems
Exclusion Criteria:
* Previous systemic treatment for metastatic NSCLC. The administration of neoadjuvant or adjuvant radiotherapy and/or chemotherapy is permitted provided it was completed major or equal 6 months prior
* Dementia or a significantly altered mental state that could affect comprehension or the ability to grant informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02336061
Study Brief:
Protocol Section:
NCT02336061